The global peripheral interventions market is projected to reach USD 12.58 billion by 2028, growing at a CAGR of 9.3%. Increasing occurrence of cardiovascular conditions, growing adoption of non-invasive procedures and advancements in peripheral interventions devices are some of the factors driving the growth of the global peripheral interventions market.
Adroit Market Research report on global peripheral interventions market gives a holistic view of the market from 2018 to 2028, which includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for historic years from 2018 to 2019, with the base year of estimation as 2020 and forecast from 2021 to 2028. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global peripheral interventions market have been studied in detail.
The global peripheral interventions market is categorized based on product and application. On the basis of product, the market is segmented into catheters, sheath, stents, guide wires, atherectomy devices, embolic devices, thrombectomy devices, IVC filters and other products. Stents dominated the market in 2020. By application, the market is segmented into vascular diseases, cancer and other chronic diseases. Vascular diseases dominated the market in 2020.
North America dominated the market for peripheral interventions in 2020, while Asia-Pacific is set to grow at the highest CAGR due to increasing approval of non-invasive techniques. Key players of the global peripheral interventions market include Abbott Laboratories, AtriCure Inc., AngioDynamics, Inc, Biotronik SE & Co. KG, Cook Medical, W.L. Gore & Associates, Boston Scientific, Teleflex Inc., Cardinal Health, Medtronic plc, C.R. Bard among others.
Key segments of the global peripheral interventions market
Product Overview, 2018-2028 (USD Billion)
- Catheters
- Sheath
- Stents
- Guide wires
- Atherectomy devices
- Embolic devices
- Thrombectomy devices
- IVC filters
- Others
Application Overview, 2018-2028 (USD Billion)
- Vascular diseases
- Cancer
- Others
Regional Overview, 2018-2028 (USD Billion)
- North America
- U.S.
- Canada
- Europe
- Germany
- United Kingdom
- France
- Asia Pacific
- China
- Japan
- India
- South America
- Brazil
- Mexico
- Middle East & Africa
- GCC
- South Africa